June 04, 2019
Quanterix is re-engineering ultrasensitivity with the launch of the Simoa HD-X Analyzer™, the latest model fully automated Simoa bead-based immunoassay platform.
Simoa assays can detect biomarkers associated with brain injury and disease at much earlier stages to understand the long term effects and disease pathology.
The Quanterix SR-X is the latest instrument powered by Simoa® technology offering researchers access to ultra-sensitive biomarker detection capabilities in a compact affordable system.
The Simoa p24 Antigen Assay is an ultra-sensitive digital immunoassay providing 1,000 times improvement in detection limits compared with a traditional ELISA. The method can be used to detect early reactivation of infectious virus from latent reservoirs and determine efficacy of drugs and therap